Veröffentlichungsdatum: 30 April 2019
Projektträger – zwischengeschaltetes Finanzinstitut
DRAEGERWERK AG & CO KGAA
This project consists of research, development and innovation (RDI) investments related to medical technology.
This project concerns new product development, product improvements and product maintenance targeted for respiratory care, anaesthesia, thermoregulation, patient monitoring, clinical information technology (IT), workplace infrastructure and workplace and system functionality.
- Industrie - Verarbeitendes Gewerbe/Herstellung von Waren
Vorgeschlagene EIB-Finanzierung (voraussichtlicher Betrag)
EUR 110 million
Gesamtkosten (voraussichtlicher Betrag)
EUR 277 million
Research and development (R&D) activities included in the project will not materially change current R&D practice and will be carried out within existing facilities already authorised for the same purpose and would therefore not require an Environmental Impact Assessment (EIA) under the Directive 2011/92/EU as amended.
The promoter is a private company not operating in the utilities sector and is thus not covered by EU Directives on procurement.
Unterzeichnet - 4/04/2019
Before financing approval by the Board of Directors, and before loan signature, projects are under appraisal and negotiation. The data provided on this page is therefore indicative and cannot be considered to represent official EIB policy (see also the Explanatory notes).